CSS LLC’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

CSS LLC’s Portfolio AYLA Stock Details AYLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-64,180	Closed	-$64K	–	1216
2022 Q3	$64K	Hold	64,180	–	–	﹤0.01%	860
2022 Q2	$70K	Buy	64,180 +31,878	+99%	+$72.8K	﹤0.01%	921
2022 Q1	$129K	Buy	32,302 +16,900	+110%	+$87.8K	﹤0.01%	906
2021 Q4	$131K	Buy	+15,402	New	+$153K	﹤0.01%	974

Other funds holding AYLA

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

APP

Avantax Planning Partners Dubuque, Iowa $4.02B AUM 20% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CSS LLC's AYLA Position: Q4 2022 in Review

CSS LLC sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q4 2022, closing a stake of 64,180 shares — an estimated $64K sold.

CSS LLC first reported a position in AYLA in Q4 2021 and held it in 4 quarters. The position peaked at $131K in Q4 2021. 11 funds tracked by Wall St. Rank hold AYLA as of Q4 2022.

CSS LLC reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
CSS LLC sold 64,180 Ayala Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $64K.
CSS LLC first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
CSS LLC's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $131K in Q4 2021.
11 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on CSS LLC's 13F filing for Q4 2022, filed 14 Feb 2023.